 cyclophosphamid methotrex fluorouracil doxorubicin adjuv treatment resect breast cancer posit axillari node attempt current adjuv result patient posit axillari lymph node novemb prospect random studi effect intraven IV cyclophosphamid methotrex fluorouracil cmf cours cmf cours adriamycin doxorubicin farmitalia carlo erba milan itali cours result total patient studi decemb cmf chemotherapi IV total cours cours cours adriamycin drug week dose drug administr week face myelosuppress day treatment median follow-up month signific differ evid treatment group term relapse-fre cmf cmf adriamycin total surviv cmf cmf adriamycin drug treatment devoid life-threaten toxic present result menopaus statu adriamycin cmf treatment outcom cmf role adriamycin adjuv set good result studi expens minim toxic full-dos cmf present adjuv chemotherapi choic patient posit node